Evaluation of the Antalgic Effect of Puressentiel Joints and Muscles - Gel on Joint Pain of the Knee (EVAPURGEL)

Puressentiel

Status

Unknown

Conditions

Joint Pain

Pain

Treatments

Device: Joint and muscle gel Puressentiel

Study type

Interventional

Funder types

Industry

Identifiers

NCT04736563

Puressentiel laboratory

Details and patient eligibility

About

This clinical trial aims to evaluate the antalgic effect of Puressentiel Joints and Muscles - Gel with 14 essential oils for 12 weeks on knee joint pain in 45 patients suffering from chronic pain related to arthritis of the knee. The evaluation of the puressentiel antalgic effect Joints and Muscles - Gel with 14 essential oils will be done by an algo-functional score of WOMAC based on items of pain, joint stiffness and locomotor function (main criterion), a visual analog scale EVA (graduated from 1 to 10) of the pain by self-assessment of the patient during the consultation and the number of daily analgesics and anti-inflammatory drugs (secondary criteria).

Full description

This clinical trial aims to evaluate the antalgic effect of Puressentiel Joints and Muscles - Gel with 14 essential oils for 12 weeks on knee joint pain in 45 patients suffering from chronic pain related to arthritis of the knee. The patients included in the study will be consultants from the Department of Physical Medicine, Rehabilitation and Sports Trauma at Foch Hospital in Suresnes and will have to present chronic pain related to arthritis of the knee either with or without antalgic and anti-inflammatory treatment. The evaluation of the puressentiel antalgic effect Joints and Muscles - Gel with 14 essential oils will be evaluated by an algo-functional score of WOMAC based on items of pain, joint stiffness and locomotor function (main criterion), a visual analog scale EVA (graduated from 1 to 10) of the pain by self-assessment of the patient during each visit and the number of daily antalgic and anti-inflammatory drugs (secondary criteria).

Enrollment

40 estimated patients

Sex

All

Ages

45 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject smust be able to understand the terms of the written informed consent and must agree to date and sign it before any study procedure is carried out,
Patient having signed the informed consent
Aged 45 to 90
With chronic osteoarthritis of the knee
Patient with or without analgesic and anti-inflammatory treatment

Exclusion criteria

Patient at the stage of surgical osteoarthritis (grade 4 plus limitation of amplitude)
Patient with a limited walking perimeter (<100m) for any reason whatsoever
Patient allergic to one of the components of the study product
Patient not benefiting from social security
Patient cannot be followed for the duration of the study
Participation in another clinical trial within 30 days before V0
Subjects who cannot understand or perform study procedures.
Pregnant or breastfeeding women
People with a history of convulsive or epileptic disorders
People allergic to salicylates.